A detailed history of Baillie Gifford & CO transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Baillie Gifford & CO holds 14,876 shares of MEDP stock, worth $5.18 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,876
Previous 5,398 175.58%
Holding current value
$5.18 Million
Previous $2.22 Million 123.12%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$320.58 - $457.29 $3.04 Million - $4.33 Million
9,478 Added 175.58%
14,876 $4.96 Million
Q2 2024

Jul 25, 2024

BUY
$372.0 - $424.34 $2.01 Million - $2.29 Million
5,398 New
5,398 $2.22 Million

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.8B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Baillie Gifford & CO Portfolio

Follow Baillie Gifford & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

News

Stay updated on Baillie Gifford & CO with notifications on news.